Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Daniel J. Mitchell currently holds 6,000 shares of ARCA biopharma, Inc. (ABIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel J. Mitchell has been a net buyer of ABIO stock. They have purchased $1.3M and sold $478.3K worth of shares.
Daniel J. Mitchell's most recent insider trade was on Jan 30, 2024, when they sold 6,000 shares at $0.00 per share.
Daniel J. Mitchell serves as Executive at ARCA biopharma, Inc. (ABIO). They have executed 125 insider transactions totaling $1.8M over their tenure at the company.
Daniel J. Mitchell holds the position of Executive at ARCA biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Daniel J. Mitchell has shown a buying trading pattern, with $1.3M in total purchases and $478.3K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Daniel J. Mitchell was on Mar 11, 2016, when they sold $177.9K worth of GBIM shares. This transaction involved 76,662 shares at $2.32 per share.
Daniel J. Mitchell currently owns 6,000 shares of ARCA biopharma, Inc. (ABIO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Daniel J. Mitchell's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Daniel J. Mitchell has 125 Form 4 filings on record as an insider at ARCA biopharma, Inc..
Set alerts for Daniel J. Mitchell and 40,000+ other insiders.